Y14A Antibody

What is Y14A/RBM8A and what are its primary cellular functions?

Y14A/RBM8A is an RNA recognition motif-containing protein that forms heterodimers with MAGOH and serves as a core component of the exon junction complex (EJC). This protein plays essential roles in:

• Pre-mRNA splicing as a component of the spliceosome

• mRNA metabolism and surveillance

• Nonsense-mediated decay (NMD) pathway

• Cell cycle regulation, particularly at the M phase

• Cell differentiation and apoptosis regulation

The protein contains an RNA-recognition motif and a C-terminal serine/arginine (RS) repeat-containing region which undergoes modifications such as phosphorylation and methylation . These modifications regulate its function and localization.

In cancer research, RBM8A has emerged as a molecule of interest due to its varied expression across tumor types . Studies have shown that RBM8A may act as a proto-oncogene, with increased expression correlating with poor prognosis in certain cancers .

What are the structural characteristics and molecular properties of Y14A/RBM8A?

Y14A/RBM8A has the following key structural properties:

The C-terminal RS repeat-containing sequence exhibits potential for nucleolar localization, while the N-terminal region contributes to its nuclear targeting . Most synthesized RBM8A proteins are rapidly phosphorylated in cells before complex formation with MAGOH occurs .

What are the validated applications for Y14A/RBM8A antibodies in research?

Based on multiple sources, Y14A/RBM8A antibodies have been validated for several experimental applications:

When selecting an application, consider your research question:

• WB for expression level analysis

• IHC/IF for localization studies

• IP for examining protein-protein interactions

• ELISA for quantitative measurement in complex samples

How should phosphorylation status of Y14A/RBM8A be analyzed experimentally?

The phosphorylation status of Y14A/RBM8A is physiologically significant and can be analyzed using these approaches:

• Phos-tag gel electrophoresis: This specialized technique effectively separates phosphorylated from non-phosphorylated forms of the protein. Studies have used this method to reveal modifications of serine residues 166 and 168 .

• Mutational analysis: Research has shown that a single substitution at position 168 can concomitantly abolish the phosphorylation of serine 166, suggesting priority in phosphorylation events .

• Inhibitor studies: MAGOH binding has been demonstrated to have an inhibitory effect on RBM8A phosphorylation both in vitro and in vivo .

• Sample preparation considerations:

  • Use phosphatase inhibitors during extraction

  • Analyze samples quickly after preparation

  • Consider cell lysis conditions that preserve phosphorylation status

What controls are essential when using Y14A/RBM8A antibodies?

When utilizing Y14A/RBM8A antibodies, inclusion of appropriate controls is critical:

For validation of immunohistochemical results, the approach used in clinical antibody validation studies provides a useful model. For example, one study examining CLDN18 antibodies established agreement rates between different antibodies and platforms, measuring parameters such as:

How can researchers effectively study the role of Y14A/RBM8A in cancer progression?

Y14A/RBM8A has been implicated in cancer progression through multiple mechanisms:

How does Y14A/RBM8A interact with the exon junction complex and what experimental approaches can examine this?

Y14A/RBM8A is a core component of the exon junction complex with specific interactions that can be studied through various techniques:

• Heterodimer formation with MAGOH:

  • The MAGOH-RBM8A heterodimer inhibits the ATPase activity of EIF4A3

  • This interaction traps the ATP-bound EJC core onto spliced mRNA in a stable conformation

  • Co-immunoprecipitation assays can effectively demonstrate this interaction

• Role in nonsense-mediated decay:

  • The MAGOH-RBM8A heterodimer is a component of the NMD pathway

  • It interacts with EJC key regulator PYM1 leading to EJC disassembly in the cytoplasm

  • This can be studied through RNA decay assays after knockdown of RBM8A

• Translation enhancement:

  • The complex recruits EJC-bearing spliced mRNAs to the ribosomal 48S preinitiation complex

  • Polysome profiling after RBM8A depletion can reveal its impact on translation

• Selective RNA binding:

  • Associates preferentially with mRNAs produced by splicing

  • Does not interact with pre-mRNAs, introns, or mRNAs from intronless cDNAs

  • RNA immunoprecipitation (RIP) and CLIP-seq techniques can map these interactions

What methodologies can distinguish between different post-translational modifications of Y14A/RBM8A?

Post-translational modifications (PTMs) of Y14A/RBM8A significantly impact its function. These approaches can help distinguish different modifications:

• Phosphorylation analysis:

  • Phos-tag gel electrophoresis effectively separates phosphorylated forms

  • A single substitution at position 168 abolishes phosphorylation of serine 166, suggesting sequential phosphorylation events

  • Phosphatase treatments can confirm phosphorylation status

• Mutagenesis approaches:

  • Site-directed mutagenesis of serine residues (particularly 166 and 168)

  • Expression of phospho-mimetic (S→D/E) or phospho-null (S→A) mutants

  • Analysis of localization changes upon mutation (deletion or dephosphorylation mimic mutants show shifted localization from the nucleoplasmic region)

• Protein interaction studies:

  • MAGOH binding inhibits Y14A/RBM8A phosphorylation both in vitro and in vivo

  • Co-immunoprecipitation with and without phosphatase treatment can reveal modification-dependent interactions

• Mass spectrometry:

  • Tandem mass spectrometry can identify precise sites and types of modifications

  • Quantitative approaches can determine stoichiometry of modifications

How should researchers interpret variable bands in Western blot analysis of Y14A/RBM8A?

When analyzing Western blot results for Y14A/RBM8A, you may encounter variability. Here's how to interpret common patterns:

• Multiple bands or band shifts:

  • Expected molecular weight is 20-24 kDa

  • Higher molecular weight bands (24 kDa vs. calculated 20 kDa) often indicate phosphorylated forms

  • Phos-tag gels can confirm if shifts are due to phosphorylation

  • Treatment with phosphatase can collapse multiple bands into a single lower band

• Tissue-specific variations:

  • Expression varies across tissues with higher levels in immune-related cells

  • Nuclear vs. cytoplasmic fractionation may show different patterns

  • Validation in multiple cell lines is recommended (HEK-293T, Jurkat, HeLa, and MDA-MB-453s cells have shown positive Western blot results)

• Antibody-dependent differences:

  • Different antibodies may recognize distinct epitopes or forms

  • Some antibodies may be sensitive to post-translational modifications

  • Validation with multiple antibodies is recommended for confirmation

  • Between-antibody precision testing can establish reliability (as used in clinical antibody validation)

How does protein localization inform understanding of Y14A/RBM8A function?

The subcellular localization of Y14A/RBM8A provides important functional insights:

• Nuclear vs. cytoplasmic distribution:

  • Y14A/RBM8A localization is regulated by both the N-terminal localization signal and C-terminal RS repeat-containing region

  • Deletion or dephosphorylation mimic mutants of the C-terminal region show shifted localization from the nucleoplasmic region

  • The C-terminal RS repeat-containing sequence itself exhibits potential for nucleolar localization

• MAGOH binding effects:

  • The regulation of Y14A localization by the C-terminal region is exquisitely controlled by MAGOH binding

  • This interaction should be considered when interpreting localization patterns

• Experimental approaches:

  • Immunofluorescence with specific antibodies can visualize localization patterns

  • Nuclear/cytoplasmic fractionation followed by Western blot provides quantitative assessment

  • Tagged constructs (GFP/FLAG) can be used for live cell imaging but may affect localization

• Functional implications:

  • Nuclear localization generally indicates involvement in splicing and EJC assembly

  • Cytoplasmic localization suggests roles in mRNA transport, surveillance, or translation

  • Nucleolar localization may indicate involvement in ribosome biogenesis

What emerging approaches show promise for antibody development and characterization?

Recent innovations in antibody technology relevant to Y14A/RBM8A research include:

How can researchers interpret contradictory findings about Y14A/RBM8A function?

When encountering contradictory results regarding Y14A/RBM8A function, consider these reconciliation approaches:

• Context-dependent effects:

  • Y14A/RBM8A shows tissue-specific expression patterns, with higher expression in immune-related cells than in non-immune organs

  • Cancer vs. normal tissue contexts may produce different functional outcomes

  • Expression level vs. functional significance distinctions (high expression may not always correlate with heightened function)

• Methodological differences:

  • Antibody-specific factors: epitope recognition, modification sensitivity

  • Knockdown vs. knockout approaches may yield different results

  • Acute vs. chronic depletion can reveal different aspects of function

• Specific experimental considerations:

  • The phosphorylation status of Y14A/RBM8A affects both function and localization

  • MAGOH binding inhibits phosphorylation and affects localization

  • Consider the impact of tags or fusion proteins on function

• Comprehensive analysis approach:

  • Integrate multiple data types (expression, localization, interaction, functional)

  • Consider both direct and indirect effects

  • Examine tissue-specific regulatory networks